TIGERMED repurchases 43,100 A-shares; outstanding share count trimmed to 711.05 million

Bulletin Express06-25

Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed that it bought back 43,100 A-shares on 25 June 2026 via the Shenzhen Stock Exchange.

The repurchase was executed within a price range of RMB 42.44–42.78 per share, representing a volume-weighted average repurchase cost of approximately RMB 42.65 per share. Aggregate consideration amounted to about RMB 1.84 million.

Following the transaction, TIGERMED’s issued share capital (excluding treasury shares) declined by 0.0061 % to 711.05 million shares. Concurrently, the company’s treasury stock rose to 26.85 million shares. The total number of issued shares remains unchanged at 737.90 million because the repurchased shares are being held in treasury and have not been cancelled.

The company confirmed that the buyback complied with Shenzhen Stock Exchange regulations and the relevant Hong Kong Stock Exchange rules governing share repurchases.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1160040228?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-25 16:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160040228","market":"hk","top_or_hot":-1,"title":"TIGERMED repurchases 43,100 A-shares; outstanding share count trimmed to 711.05 million","media":"Bulletin Express","content":"<p>Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed that it bought back 43,100 A-shares on 25 June 2026 via the Shenzhen Stock Exchange.</p>\n<p>The repurchase was executed within a price range of RMB 42.44–42.78 per share, representing a volume-weighted average repurchase cost of approximately RMB 42.65 per share. Aggregate consideration amounted to about RMB 1.84 million.</p>\n<p>Following the transaction, TIGERMED’s issued share capital (excluding treasury shares) declined by 0.0061 % to 711.05 million shares. Concurrently, the company’s treasury stock rose to 26.85 million shares. The total number of issued shares remains unchanged at 737.90 million because the repurchased shares are being held in treasury and have not been cancelled.</p>\n<p>The company confirmed that the buyback complied with Shenzhen Stock Exchange regulations and the relevant Hong Kong Stock Exchange rules governing share repurchases.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TIGERMED repurchases 43,100 A-shares; outstanding share count trimmed to 711.05 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTIGERMED repurchases 43,100 A-shares; outstanding share count trimmed to 711.05 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-25 16:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed that it bought back 43,100 A-shares on 25 June 2026 via the Shenzhen Stock Exchange.</p>\n<p>The repurchase was executed within a price range of RMB 42.44–42.78 per share, representing a volume-weighted average repurchase cost of approximately RMB 42.65 per share. Aggregate consideration amounted to about RMB 1.84 million.</p>\n<p>Following the transaction, TIGERMED’s issued share capital (excluding treasury shares) declined by 0.0061 % to 711.05 million shares. Concurrently, the company’s treasury stock rose to 26.85 million shares. The total number of issued shares remains unchanged at 737.90 million because the repurchased shares are being held in treasury and have not been cancelled.</p>\n<p>The company confirmed that the buyback complied with Shenzhen Stock Exchange regulations and the relevant Hong Kong Stock Exchange rules governing share repurchases.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03347","symbol_name":"泰格医药","start_time":0,"source_url":"","article_id":"1160040228","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160040228","pubTimestamp":1782377175,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed that it bought back 43,100 A-shares on 25 June 2026 via the Shenzhen Stock Exchange. The repurchase was executed within a price range of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03347":"泰格医药"},"translate_title":"泰格医药回购4.31万股A股；流通股数量削减至7.1105亿股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03347":1},"content_text":"Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed that it bought back 43,100 A-shares on 25 June 2026 via the Shenzhen Stock Exchange.\nThe repurchase was executed within a price range of RMB 42.44–42.78 per share, representing a volume-weighted average repurchase cost of approximately RMB 42.65 per share. Aggregate consideration amounted to about RMB 1.84 million.\nFollowing the transaction, TIGERMED’s issued share capital (excluding treasury shares) declined by 0.0061 % to 711.05 million shares. Concurrently, the company’s treasury stock rose to 26.85 million shares. The total number of issued shares remains unchanged at 737.90 million because the repurchased shares are being held in treasury and have not been cancelled.\nThe company confirmed that the buyback complied with Shenzhen Stock Exchange regulations and the relevant Hong Kong Stock Exchange rules governing share repurchases.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.0","shortVersion":"4.45.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1160040228","isCrawlerRequest":true}